These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 3971358)
41. Evaluation of cell-killing effects of 1-beta-D-arabinofuranosylcytosine and daunorubicin by a new computer-controlled in vitro pharmacokinetic simulation system. Kishi S; Goto N; Nakamura T; Ueda T Cancer Res; 1999 Jun; 59(11):2629-34. PubMed ID: 10363985 [TBL] [Abstract][Full Text] [Related]
42. Nelarabine: a nucleoside analog with efficacy in T-cell and other leukemias. Kisor DF Ann Pharmacother; 2005 Jun; 39(6):1056-63. PubMed ID: 15870141 [TBL] [Abstract][Full Text] [Related]
43. Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance. Oh-ishi J; Kataoka T; Tsukagoshi S; Sakurai Y; Shibukawa M; Kobayashi H Cancer Res; 1981 Jun; 41(6):2501-6. PubMed ID: 7237444 [TBL] [Abstract][Full Text] [Related]
44. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis. Nandy P; Lien EJ; Avramis VI Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093 [TBL] [Abstract][Full Text] [Related]
45. Metabolism and actions of 2-chloro-9-(2-deoxy-2-fluoro-beta-D- arabinofuranosyl)-adenine in human lymphoblastoid cells. Xie C; Plunkett W Cancer Res; 1995 Jul; 55(13):2847-52. PubMed ID: 7540950 [TBL] [Abstract][Full Text] [Related]
46. Long intracellular retention of 4'-thio-arabinofuranosylcytosine 5'-triphosphate as a critical factor for the anti-solid tumor activity of 4'-thio-arabinofuranosylcytosine. Someya H; Waud WR; Parker WB Cancer Chemother Pharmacol; 2006 Jun; 57(6):772-80. PubMed ID: 16180016 [TBL] [Abstract][Full Text] [Related]
47. Changes in sensitivity to anticancer drugs during TPA-induced cellular differentiation in a human T-lymphoblastoid cell line (MOLT-4). Takimoto T; Kubota M; Tsuruta S; Kitoh T; Tanizawa A; Akiyama Y; Kiriyama Y; Mikawa H Leukemia; 1988 Jul; 2(7):443-6. PubMed ID: 3260648 [TBL] [Abstract][Full Text] [Related]
48. Direct relationship of marrow cell growth and 1-beta-D-arabinofuranosylcytosine metabolism. Karp JE; Donehower RC; Dole GB; Burke PJ Cancer Res; 1984 Nov; 44(11):5046-50. PubMed ID: 6488163 [TBL] [Abstract][Full Text] [Related]
49. Reduced drug incorporation into DNA and antiapoptosis as the crucial mechanisms of resistance in a novel nelarabine-resistant cell line. Yamauchi T; Uzui K; Nishi R; Shigemi H; Ueda T BMC Cancer; 2014 Jul; 14():547. PubMed ID: 25070259 [TBL] [Abstract][Full Text] [Related]
50. Deoxyguanosine enhancement of cytarabine nucleotide accumulation in human leukemia cells. Akman SA; Ross DD; Joneckis CC; Fox BM; Bachur NR Cancer Treat Rep; 1985; 69(7-8):851-7. PubMed ID: 4016794 [TBL] [Abstract][Full Text] [Related]
51. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine. Kufe D; Herrick D; Crumpacker C; Schnipper L Cancer Res; 1984 Jan; 44(1):69-73. PubMed ID: 6317173 [TBL] [Abstract][Full Text] [Related]
52. Modulatory activity of 2',2'-difluorodeoxycytidine on the phosphorylation and cytotoxicity of arabinosyl nucleosides. Gandhi V; Plunkett W Cancer Res; 1990 Jun; 50(12):3675-80. PubMed ID: 2340517 [TBL] [Abstract][Full Text] [Related]
53. Degradation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human leukemic myeloblasts and lymphoblasts. Jamieson GP; Finch LR; Snook M; Wiley JS Cancer Res; 1987 Jun; 47(12):3130-5. PubMed ID: 3472653 [TBL] [Abstract][Full Text] [Related]
54. 1-beta-D-arabinofuranosylcytosine-induced malignant transformation of hamster and rat cells in culture. Kouri RE; Kurtz SA; Price PJ; Benedict WF Cancer Res; 1975 Sep; 35(9):2413-9. PubMed ID: 1149043 [TBL] [Abstract][Full Text] [Related]
55. The novel nucleoside transport system exhibited by NB4 cells, csg, transports deoxyguanosine analogues, including ara-G. Flanagan SA; Gandhi V; Secrist JA; Meckling KA Biochem Pharmacol; 2003 Sep; 66(5):733-7. PubMed ID: 12948853 [TBL] [Abstract][Full Text] [Related]
56. Resistance to mitochondrial- and Fas-mediated apoptosis in human leukemic cells with acquired resistance to 9-beta-D-arabinofuranosylguanosine. Månsson E; Stridh H; Albertioni F Biochem Biophys Res Commun; 2002 Nov; 298(3):338-44. PubMed ID: 12413945 [TBL] [Abstract][Full Text] [Related]
57. Deoxyadenosine-resistant human T lymphoblasts with elevated 5'-nucleotidase activity. Carson DA; Carrera CJ; Wasson DB; Iizasa T Biochim Biophys Acta; 1991 Jan; 1091(1):22-8. PubMed ID: 1995064 [TBL] [Abstract][Full Text] [Related]
58. Establishment of human KB cells resistant to 1-beta-D-arabinofuranosylcytosine, and mechanisms of cellular resistance in isolated clones. Tsuruo T; Naganuma K; Iida H; Sone S; Ishii K; Tsubura E; Tsukagoshi S; Sakurai Y Gan; 1984 Aug; 75(8):690-8. PubMed ID: 6489676 [TBL] [Abstract][Full Text] [Related]